CIK 0000882796 · Large accelerated filer
BIOCRYST PHARMACEUTICALS INC
Sign in to watch- Ticker
- BCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 621413174
- Phone
- 919-859-1302
- Business address
- 4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-12-14 | Gayer Charles K Chief Commercial Officer | Grant or award · Emp. Stock Option (Right to Buy) | +164,000 | 164,000 | ||
| 2021-12-14 | Babu Yarlagadda S Chief Discovery Officer | Grant or award | +35,000 | 250,056 | ||
| 2021-12-14 | Babu Yarlagadda S Chief Discovery Officer | Grant or award · Emp. Stock Option (Right to Buy) | +164,000 | 164,000 | ||
| 2021-12-14 | Thackray Helen M. Chief R&D Officer | Grant or award | +44,000 | 144,000 | ||
| 2021-12-14 | Thackray Helen M. Chief R&D Officer | Grant or award · Emp. Stock Option (Right to Buy) | +205,000 | 205,000 | ||
| 2021-12-14 | Barnes Alane P Chief Legal Officer | Grant or award | +75,000 | 221,969 | ||
| 2021-12-14 | Barnes Alane P Chief Legal Officer | Grant or award · Emp. Stock Option (Right to Buy) | +164,000 | 164,000 | ||
| 2021-12-14 | Doyle Anthony Chief Financial Officer | Grant or award | +115,000 | 208,719 | ||
| 2021-12-14 | Doyle Anthony Chief Financial Officer | Grant or award · Emp. Stock Option (Right to Buy) | +164,000 | 164,000 | ||
| 2021-12-14 | Sheridan William P Chief Medical Officer | Grant or award | +35,000 | 50,791 | ||
| 2021-12-14 | Sheridan William P Chief Medical Officer | Grant or award · Emp. Stock Option (Right to Buy) | +164,000 | 164,000 | ||
| 2021-12-14 | Stonehouse Jon P President & CEO | Grant or award | +123,000 | 901,602 | ||
| 2021-12-14 | Stonehouse Jon P President & CEO | Grant or award · Emp. Stock Option (Right to Buy) | +574,500 | 574,500 | ||
| 2021-09-01 | Stonehouse Jon P President & CEO | Gift | −5,000 | 783,602 | ||
| 2021-09-01 | Stonehouse Jon P President & CEO | Gift | −5,000 | 778,602 | ||
| 2021-09-01 | Stonehouse Jon P President & CEO | Gift | +5,000 | 5,000 | ||
| 2021-09-01 | Stonehouse Jon P President & CEO | Gift | +5,000 | 5,000 |
Page 18 of 18 · 357 trades